İNANÇ, G. N. Et Al. 2017. Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?. ACR/ARHP 2017 , (SAN DİEGO, United States Of America).

İNANÇ, G. N., ÖZEN, G., YALÇINKAYAN, Y., DALKILIÇ, H. E., KOCA, S. S., CAN, G., ... KARATAŞ, A.(2017). Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry? . ACR/ARHP 2017, SAN DİEGO, United States Of America

İNANÇ, GÜZİDE Et Al. "Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?," ACR/ARHP 2017, SAN DİEGO, United States Of America, 2017

İNANÇ, GÜZİDE N. Et Al. "Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?." ACR/ARHP 2017 , SAN DİEGO, United States Of America, 2017

İNANÇ, G. N. Et Al. (2017) . "Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?." ACR/ARHP 2017 , SAN DİEGO, United States Of America.

@conferencepaper{conferencepaper, author={GÜZİDE NEVSUN İNANÇ Et Al. }, title={Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?}, congress name={ACR/ARHP 2017}, city={SAN DİEGO}, country={United States Of America}, year={2017}}